Case studies : Stahl's essential psychopharmacology. Volume 3 / edited by Takesha Cooper, Gerald Maguire, Stephen M. Stahl. [electronic resource]

Format:

Book

Contributor:

Cooper, Takesha, editor.

Maguire, Gerald, editor.

Stahl, Stephen M., 1951- editor.

Series:

Cambridge medicine (Series)

Cambridge medicine

Language:

English

Subjects (All):

Mental illness--Chemotherapy--Case studies.

Mental illness.

Psychopharmacology--Examinations, questions, etc.

Psychopharmacology.

Psychopharmacology--Case studies.

Mental illness--Chemotherapy--Examinations, questions, etc.

Physical Description:

1 online resource (xxiii, 433 pages) : digital, PDF file(s).

Edition:

First edition.

Place of Publication:

Cambridge : Cambridge University Press, 2022.

Summary:

Following the success of the first two volumes in Stahl's Case Studies series, a brand new collection of clinical stories have been collated in Volume 3, derived from cases seen by medical students, residents and faculty from the University of California at Riverside (UCR) Department of Psychiatry and Neuroscience. The highly popular and unique user-friendly presentation of previous volumes has been maintained, with extensive use of icons, questions/answers, and tips. The cases address multifaceted issues in an understandable way and with direct relevance to the everyday experience of clinicians. Covering a wide-ranging and representative selection of clinical scenarios, each case is followed through the complete clinical encounter, from start to resolution, acknowledging all the complications, issues, decisions, twists and turns along the way. The book is about living through the treatments that work, the treatments that fail, and the mistakes made along the journey. This is psychiatry in real life.

Contents:

Cover

Half-title page

Title page

Copyright page

Contents

Introduction

List of Contributors

List of icons

List of Abbreviations

1. The Case: Wearing down a diagnosis

The Question: What are the similarities and differences between anxiety and autism spectrum disorder (ASD) in children? How does it affect treatment and prognosis?

The Psychopharmacological Dilemma: Does this patient have ananxiety disorder, which can be treated effectively with a simple regimen that has a good prognosis, or does she have an ASD, which would require a more extensive regimen and possible lifelong treatment?

Karen Clarey, Stephanie Wong, and Takesha Cooper

2. The Case: The woman who couldn't handle her lips smacking any longer

The Question: Is tardive dyskinesia permanent?

The Psychopharmacological Dilemma: Finding various options for treating tardive dyskinesia

Douglas Grover, Michael T. Ingram, Jr., and Christopher G. Fichtner

3. The Case: The depressed bipolar patient on multiple medications

The Question: Can reduction of polypharmacy optimize moodstabilization and reduce risk of subsequent manic or depressiveepisodes in this patient?

The Psychopharmacological Dilemma: Starting new medications andaltering current ones can give rise to new adverse effects

Dale Hoang, Catherine Ha, and Peter Hauser

4. The Case: The agitated patient who finally wasn't

The Question: What do you do when a patient is taking appropriate scheduled medications, but is frequently agitated and requiring medication intramuscularly (IM) or as needed on top?.

The Psychopharmacological Dilemma: This patient had a significant history of violence and required heavy utilization of emergency IM medications in addition to scheduled medications. How do you balance the safety needs of the patient and staff while still respecting consent,ethical rights, and the risk of serious side effects?

Alex J. Mageno, Nekisa Haghighat, and Arthur Leitzke

5. The Case: The George who was not psychotic but anxious and distracted

The Question: How common is psychosis seen in the spectrum of psychiatric comorbidities in DiGeorge syndrome?

The Psychopharmacological Dilemma: Treating anxiety in a patient with a comorbid medical condition, symptoms of mood elevation, and a family history of bipolar disorder

Edgar Ortega, Michael Seigler, and Takesha Cooper

6. Case 6: The man who saw enemies everywhere

The Question: What treatment options are left when nearly alltreatments have been exhausted and ineffective?

The Psychopharmacological Dilemma: Treating symptoms recalcitrant to even the most robust treatment strategies

Joshua Poole and Stephen Maurer

7. The Case: The young woman with psychosis complicated by substance use and a history of traumatic brain injury

The Question: How do you determine whether psychosis is a primary or secondary illness?

The Psychopharmacological Dilemma: Does treatment depend upon whether psychosis is due to a primary psychiatric illness?

Harika Reddy, Austin Nguy, and Sana Johnson-Quijada

8. Case 8: The woman with worsening psychosis and a mysterious rash

The Question: What do you do when a psychiatric patient on steroids develops psychosis?

The Psychopharmacological Dilemma: How to address steroid-induced psychiatric disorders

Sireena Sy, Yatna Patel, and Alexander Thanh Nguyen

9. The Case: The man without a plan.

The Question: How to diagnose and treat a patient with a coexistingattention-deficit/hyperactivity disorder (ADHD) and mood symptoms?

The Psychopharmacological Dilemma: Finding an effective medication regimen for a patient previously diagnosed with ADHD and major depressive disorder failing selective serotonin reuptake inhibitors

Alfonso Vera and Gerald Maguire

10 The Case: The anxious depressed woman who couldn't sit still

The Question: How can you distinguish between bipolar disorder with mixed features and major depressive disorder with mixed features? Is it necessary to differentiate between the two?

The Psychopharmacological Dilemma: Finding an effective regimen for recurrent, anxious depression while minimizing akathisia

Nekisa Haghighat, Charity Hall, Dennis Alters, and Gerald Maguire

11 The Case: The man who thinks it's the end of the world

The Question: Can a pandemic trigger dormant psychiatric symptoms?

The Psychopharmacological Dilemma: If some element of psychosisis personality driven, will the patient benefit from medication therapy or psychotherapy to alleviate symptoms?

Erin Fletcher, Evagelos Coskinas, and Phuong Vo

12. The Case: Sunny with a chance of depression

The Question: Can stimulants be used in the treatment of major depressive disorder?

The Psychopharmacological Dilemma: How to treat recurrent major depression in patients who are resistant to various treatments and have specific comorbidities

Madeline Saavedra, Bo Ram Yoo, Douglas Grover, and Christopher G.Fichtner

13. The Case: A not-so-simple case of anxiety

The Question: What should you do when a patient with no history of mental illness presents with sudden psychiatric complaints, significant behavioral changes, and a variety of physical symptoms?.

The Psychopharmacological Dilemma: How to appropriately evaluate patients presenting with a broad range of symptoms, including physical, psychiatric, and behavioral, in order to prevent misdiagnosis of a disease

Karla P. Furlong, Roberto Castaños, and Bo Ram Yoo

14. The Case: I'm a woman in a man's body

The Question: I'm not a specialist in this area. What can I do to help recognize and alleviate gender dysphoria?

The Psychopharmacological Dilemma: Finding an effective regimen for the treatment of gender dysphoria while juggling with comorbid depression and anxiety

Sarah Grace, Matt Jason V. Llamas, and Jami Woods

15. The Case: The spacey, fidgety son with overwhelming sadness

The Question: How to manage adolescent depression with comorbid attention-deficit/hyperactivity disorder (ADHD)?

The Psychopharmacological Dilemma: Being cognizant of possible drug interactions when selecting antidepressants in adolescents who also require treatment for ADHD

Niya Larios, Casey Lester, and Carl Feinstein

16. The Case: The man who spent thousands online

The Question: Can antiemetics play a role in the treatment of psychiatric disease?

The Psychopharmacological Dilemma: How to diagnose and treat sedative-hypnotic use disorder in an elderly patient who is sensitive to medications

Saloni Singh and Carla Hammond

17. The Case: The traumatized mother who can't stop bingeing

The Question: How do you treat refractory binge eating?

The Psychopharmacological Dilemma: Will the treatment of trauma and mood disorders help resolve this patient's binge eating, or is something more needed?

Kevin Simonson and Bo Ram Yoo

18. The Case: The man who couldn't stop hitting people.

The Question: Is there a way to further optimize treatment of violent, psychotic agitation safely beyond the combination of clozapine(Clozaril) with a mood stabilizer in someone with significant cardiovascular history?

The Psychopharmacological Dilemma: How to reduce violent, psychotic behaviors in someone with an inadequate response to multiple empirical combinations of medications for treatment-resistant schizophrenia with behavioral agitation

Angharad Ames and Lawrence Faziola

19. The Case: Brexpiprazole: "an awakening"

The Question: Can the addition of brexpiprazole (Rexulti) to clozapine(Clozaril) reduce positive symptoms in a patient who has not fully responded to clozapine alone?

The Psychopharmacological Dilemma: Can "third-generation"antipsychotics, such as brexpiprazole, be utilized in combination with clozapine for treatment-resistant psychosis?

Troy Kurz, Lauren Kurz, and Samer Kamal

20. The Case: Treatment-resistant depression and opioid dependence

The Question: How can we pharmacologically address refractory major depressive disorder in a patient on buprenorphine-naloxone(Suboxone) maintenance for opioid dependency?

The Psychopharmacological Dilemma: Does ketamine interact with buprenorphine-naloxone?

Kevin Simonson and Alexander H. Truong

21. The Case: A stiff patient

The Question: What are the main clinical considerations when discontinuing clozapine (Clozaril) due to side effects?

The Psychopharmacological Dilemma: How to improve quality of life and minimize medication side effects in a patient with medication resistant psychotic symptoms

Angharad Ames, Joshua Valverde, and Gerald Maguire

22. The Case: An adolescent awakening.

The Question: How to manage an adolescent with treatment-resistant psychosis, underlying attention-deficit/hyperactivity disorder (ADHD) symptoms, daytime sedation, insomnia, and a propensity for weightgain?.

Notes:

Title from publisher's bibliographic system (viewed on 20 Oct 2021).

Includes bibliographical references.

ISBN:

9781009028042

1009028049

9781009027854

1009027859

9781009026499

1009026496